BIOLOGICAL MATERIALS LICENSE AGREEMENT INTERNAL USE ONLYBiological Materials License Agreement • October 15th, 2021 • District of Columbia
BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • October 15th, 2021
BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • May 5th, 2020 • District of Columbia
This Agreement is entered into between the U.S. Government, as represented by the U.S. Department of Agriculture, Agricultural Research Service (hereinafter referred to as “USDA”) and (company name), a (state) corporation having offices at (street address, city, and state) (hereinafter referred to as “COMPANY”).
EX-10.22 32 filename32.htm VAL-964-CHUM SIGNATURE COPY BIOLOGICAL MATERIALS LICENSE AGREEMENT BY AND BETWEEN VAL-CHUM, LIMITED PARTNERSHIP AND HEAT BIOLOGICS INC. AND TO WHICH INTERVENES CENTRE HOSPITALIER DE L’UNIVERSITÉ DE MONTREAL Page Signatures...Biological Materials License Agreement • May 5th, 2020 • Quebec
BY AND BETWEEN: VAL-CHUM, LIMITED PARTNERSHIP, a limited partnership duly constituted under the laws of the Province of Quebec, having its principal place of business at 3535, Queen-Mary road, Suite 220, Montreal, Quebec, Canada, H3V 1H8, acting through its general partner Gestion Univalor, Limited Partnership, a limited partnership duly constituted under the laws of the Province of Quebec, Canada, having its principal place of business at the same address, itself acting through its general partner Univalor Inc., a corporation duly constituted and having its head office at the same address herein represented by Philippe Calais, its President and General Manager, duly authorized for the purpose hereof as he so declares; (hereinafter referred to as: “Licensor”)
THE NATIONAL INSTITUTES OF HEALTH BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • May 5th, 2020 • District of Columbia
This Agreement is entered into between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”) through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852‑3804, U.S.A. and ____________________ (the “Licensee”), a corporation of ____________________, having an office at ________________________________________.
THE NATIONAL INSTITUTES OF HEALTH BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • April 1st, 2013 • District of Columbia
This Agreement is entered into between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”) through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804, U.S.A. and the (“Licensee”), a corporation of , having an office at .
THE NATIONAL INSTITUTES OF HEALTH BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • District of Columbia
This Agreement is entered into between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”) through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804, U.S.A. and Hookipa Biotech AG (“Licensee”), a corporation of Vienna, Austria, having an office at Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria.
BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • May 5th, 2020 • District of Columbia
This Agreement is entered into between the National Center for , Centers for Disease Control and Prevention (“CDC”), at 1600 Clifton Rd., N.E., Atlanta, Georgia, 30333, U.S.A. and ("LICENSEE"), having an office at .
BIOLOGICAL MATERIALS LICENSE AGREEMENT INTERNAL USE ONLY This Agreement is based on the model Biological Materials Internal Use Agreement adopted by the U.S. Public Health Service (“PHS”) Technology Transfer Policy Board for use by components of the...Biological Materials License Agreement • October 7th, 2024
The Licensee desires to obtain a license from the IC to use the Materials provided under this Agreement in its commercial research or product development and marketing activities. The Licensee represents that it has the facilities, personnel, and expertise to use the Materials or the Licensed Products for commercial purposes and agrees to expend reasonable efforts and resources to develop the Materials or the Licensed Products for commercial use or commercial research.
BIOLOGICAL MATERIALS LICENSE AGREEMENT INTERNAL USE ONLYBiological Materials License Agreement • October 7th, 2024
PUBLIC HEALTH SERVICE BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • March 4th, 2003 • Medimmune Inc /De • Biological products, (no disgnostic substances) • District of Columbia
This Agreement is entered into between the Public Health Service ("PHS"), through the Office of Technology Transfer, National Institutes of Health, Box OTT, Bethesda, Maryland 20892, U.S.A. and MedImmune Inc. ("LICENSEE"), a corporation of Delaware, having an office at 35 West Watkins Mill Road, Gaithersburg, Maryland.
THE NATIONAL INSTITUTES OF HEALTH BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • April 18th, 2023
This Agreement is entered into between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”) through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804, U.S.A. and Hookipa Biotech AG (“Licensee”), a corporation of Vienna, Austria, having an office at Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria.
PUBLIC HEALTH SERVICE BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • September 19th, 2007 • District of Columbia
This Agreement is entered into between the Public Health Service (“PHS”), through the National Center for Infectious Diseases, the Center for Disease and Prevention (“CDC”), 1600 Clifton Road, N.E., Mailstop E-51, Atlanta, GA 30333, U.S.A. and Emory University (“EMORY”) through the Office of Technology Transfer, 1599 Clifton Road NE, Fourth Floor, Atlanta, Georgia 30322, U.S.A. (collectively “LICENSORS”) and
BIOLOGICAL MATERIALS LICENSE AGREEMENT INTERNAL USE ONLY This Agreement is based on the model Biological Materials Internal Use Agreement adopted by the U.S. Public Health Service (“PHS”) Technology Transfer Policy Board for use by components of the...Biological Materials License Agreement • October 14th, 2016
The Licensee desires to obtain a license from the IC to use the Materials provided under this Agreement in its commercial research or product development and marketing activities. The Licensee represents that it has the facilities, personnel, and expertise to use the Materials or the Licensed Products for commercial purposes and agrees to expend reasonable efforts and resources to develop the Materials or the Licensed Products for commercial use or commercial research.
BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • July 6th, 2020 • District of Columbia
This Agreement is entered into between the U.S. Government, as represented by the U.S. Department of Agriculture, Agricultural Research Service (hereinafter referred to as “USDA”) and (company name), a (state) corporation having offices at (street address, city, and state) (hereinafter referred to as “COMPANY”).
ContractBiological Materials License Agreement • August 16th, 2023 • Baudax Bio, Inc. • Services-misc health & allied services, nec
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and the registrant customarily and actually treats as private and confidential.
PUBLIC HEALTH SERVICE BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • October 14th, 2016 • District of Columbia
The Licensee desires to obtain a license from the IC to use the Materials provided under this Agreement in its commercial research or product development and marketing activities. The Licensee represents that it has the facilities, personnel, and expertise to use the Materials or the Licensed Products for commercial purposes and agrees to expend reasonable efforts and resources to develop the Materials or the Licensed Products for commercial use or commercial research.
